门诊加重的尽力衰竭作为治疗靶点:综述
本文提出门诊加重的尽力衰竭(WHF)是独立于就诊场所的高危临床状态,患者预后与住院WHF相似。多数住院WHF患者病程不复杂且仅用静脉利尿剂,门诊加强管理或可使部分患者免于住院。门诊WHF在随机临床试验中关注极少,但具备利于试验研究的特征,是治疗突破的重要机会。
要点
- 门诊WHF与住院WHF预后相似,应视为独立于就诊场所的临床实体。
- 多数WHF患者充血症状逐渐起病,存在门诊干预以阻断恶化、避免住院的窗口。
- 门诊WHF在随机临床试验中关注极少,但具备利于开展临床试验的高危特征。
核心结论
- 门诊WHF是独立于就诊场所的高危临床状态,其预后与住院WHF相似。
- 减少心衰住院的努力应包括开发针对门诊WHF的有效治疗和照护策略。
- 门诊WHF人群是治疗进展的重要机会,可能从根本上改变心衰照护模式。
研究设计与样本
- 本文为叙述性综述,讨论门诊WHF的概念、门诊治疗WHF替代住院的依据与数据,以及开发门诊「拦截性」治疗的机会与策略。
主要发现
- WHF传统上与因症状加重住院同义,但许多患者在门诊经历WHF且预后同样不良。
- 住院WHF患者多数临床病程不复杂,静脉治疗仅用利尿剂。
- 多数WHF患者充血体征和症状逐渐起病,为有效治疗阻断恶化、避免住院提供潜在窗口。
- 门诊WHF在随机临床试验中关注极少,但该高危人群具备利于有效临床试验的关键特征。
关键数值与推荐
- WHF传统上等同于因症状加重住院。
- 住院WHF患者多数临床病程不复杂,静脉治疗仅用利尿剂。
- 多数WHF患者充血体征和症状逐渐起病。
临床怎么用
- 应将门诊WHF识别为独立于就诊场所的高危状态并加以关注。
- 改进门诊临床充血管理工具有望使更大比例住院患者在医院外获得可比照护。
- 利用WHF症状逐渐起病的窗口,开发门诊「拦截性」治疗以阻断恶化并避免住院。
局限性
- 门诊WHF在随机临床试验中关注极少,相关治疗证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hospitalizations for worsening heart failure (WHF) represent an enormous public health and financial burden, with physicians, health systems, and payers placing increasing emphasis on hospitalization prevention. In addition, maximizing time out of the hospital is an important patient-centered outcome. In this review, we discuss the concept of outpatient WHF, highlight the rationale and data for the outpatient treatment of WHF as an alternative to hospitalization, and examine opportunities and strategies for developing outpatient "interceptive" therapies for treatment of worsening symptoms and prevention of hospitalization. OBSERVATIONS: Worsening heart failure has traditionally been synonymous with an episode of in-hospital care for worsening symptoms. While WHF often leads to hospitalization, many patients experience WHF in the outpatient setting and carry a similarly poor prognosis. These findings support WHF as a distinct condition, independent of location of care. For those that are hospitalized, most patients have an uncomplicated clinical course, with diuretics as the only intravenous therapy. Although complicated scenarios exist, it is conceivable that improved tools for outpatient management of clinical congestion would allow a greater proportion of hospitalized patients to receive comparable care outside the hospital. Most patients with WHF have a gradual onset of congestive signs and symptoms, offering a potential window in which effective therapy may abort continued worsening and obviate the need for hospitalization. To date, outpatient WHF has received minimal attention in randomized clinical trials, but this high-risk group possesses key features that favor effective clinical trial investigation. CONCLUSIONS AND RELEVANCE: As the public health and economic burdens of heart failure continue to grow, recognizing the entity of outpatient WHF is critical. Efforts to reduce heart failure hospitalization should include developing effective therapies and care strategies for outpatient WHF. The outpatient WHF population represents a major opportunity for therapeutic advancements that could fundamentally change heart failure care delivery.
引用
- Greene SJ, Mentz RJ, Felker GM, et al. Outpatient Worsening Heart Failure as a Target for Therapy: A Review. JAMA Cardiol. 2018. PMID: 29387880. doi:10.1001/jamacardio.2017.5250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。